James D'Rozario

6PUBLICATIONS
21CO-AUTHORS
HaematologyAutoimmunityInfant and child healthMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2022
Incidence of chronic renal injury in patients undergoing autologous stem cell transplant therapy.

Chloe Dawson, Emma Palfreyman, Robin Parisotto

|Nov 08, 2021
Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so 'pure'.

Lucy Aitken, Ronak Patel, James D'Rozario

|Aug 23, 2021
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.

Nada Hamad, Michelle Ananda-Rajah, Nicole Gilroy

|Oct 19, 2019
GSTZ1 genotypes correlate with dichloroacetate pharmacokinetics and chronic side effects in multiple myeloma patients in a pilot phase 2 clinical trial.

Dan Dan Tian, Samuel K Bennett, Lucy A Coupland

|Jun 18, 2019
Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL.

James D'Rozario, Samuel K Bennett

|Mar 12, 2017
Inhibition of Pol I transcription treats murine and human AML by targeting the leukemia-initiating cell population.

Nadine Hein, Donald P Cameron, Katherine M Hannan

Pageof 1

Frequent Collaborators

1 joint publications

Donald P Cameron

1 joint publications

Katherine M Hannan

1 joint publications

Amee J George

1 joint publications

Simon J Harrison